Pacira BioSciences, Inc. (PCRX)
Number of days of payables
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Payables turnover | — | — | — | — | — | |
| Number of days of payables | days | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The information provided for Pacira BioSciences, Inc. does not include specific data on the number of days of payables for the years ending December 31, 2020 through December 31, 2024. Without this data, it is not possible to calculate or analyze the number of days of payables for the company over this period. To perform a thorough analysis of the company's payables management and liquidity position, it would be essential to have the actual figures for the payables outstanding and their corresponding periods.
Peer comparison
Dec 31, 2024
Company name
Symbol
Number of days of payables
Pacira BioSciences, Inc.
PCRX
—
Abbott Laboratories
ABT
—
AbbVie Inc
ABBV
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
18.68
Amphastar P
AMPH
31.10
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
43.80
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
41.38
Catalyst Pharmaceuticals Inc
CPRX
—